ENDRA Life Sciences Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 54.25%50.86%100.00%
EBT Margin -538.30%-1,529.19%-158,669.60%-2,184.71%-10,607.97%
EBIT Margin -347.52%-1,315.63%-146,080.47%-2,284.71%-9,971.19%
EBITDA Margin -347.52%-1,315.63%-146,080.47%-2,284.71%-9,971.19%
Operating Margin -347.52%-1,315.63%-146,080.47%-2,284.71%-9,971.19%
Net Margin -538.30%-1,529.19%-158,669.60%-2,184.71%-10,607.97%
FCF Margin -255.17%-941.00%-126,376.43%-2,080.99%-6,836.54%
Efficiency
Inventory Average 0.12M0.13M0.09M0.35M
Assets Average 3.31M6.67M7.20M7.97M
Equity Average 2.19M5.76M5.50M5.96M
Invested Capital -0.89M5.28M6.25M4.76M7.78M
Asset Utilization Ratio 0.110.00
Leverage & Solvency
Debt to Equity 0.05
Debt Ratio 0.04
Equity Ratio -1.820.860.870.660.82
Dividends & Payouts
FCF Payout Ratio -0.49-0.04-0.01
Valuation
Enterprise Value -0.14M13.45M1.67M6.47M11.59M29.18M12.86M17.92M3.36M
Market Capitalization 19.05M8.14M12.64M18.82M29.18M12.86M17.92M3.36M
Return Ratios
Return on Sales -5.38%-15.29%-21.85%-106.08%
Return on Capital Employed -1.88%-1.58%-2.12%-1.65%
Return on Assets -1.63%-1.47%-1.85%-1.47%
Return on Equity -2.45%-1.70%-2.42%-1.97%